← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Maiden Holdings North America, Ltd. (MHNC) 10-Year Financial Performance & Capital Metrics

MHNC • • Insurance & Managed Care
Financial ServicesLife InsuranceSpecialized Life InsurersTerm Life & Basic Life Specialists
AboutPart of Maiden Holdings Ltd., Maiden Holdings North America Ltd. provides reinsurance services. The private company is located in the US.Show more
  • Revenue $56M -2.9%
  • Combined Ratio 62.63% -69.3%
  • Net Income -$201M -462.6%
  • Return on Equity -883.82% -105.3%
  • Medical Cost Ratio 0%
  • Operating Margin 37.37% -71.2%
  • Net Margin -356.1% -473.4%
  • ROA -30.5% -101.1%
  • Equity / Assets 3.43% -77.7%
  • Book Value per Share 0.45 +13755.1%
  • Tangible BV/Share 0.45 +13755.2%
  • Debt/Equity -
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 7178.2%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 1/9
  • ✗Shares diluted 14.6% in last year
  • ✗Expensive at 35.1x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-86.48%
3Y-
TTM2.96%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-363.15%

EPS CAGR

10Y-
5Y-
3Y-
TTM-18.46%

ROCE

10Y Avg7150.18%
5Y Avg944.38%
3Y Avg1542.56%
Latest3.2%

Peer Comparison

Term Life & Basic Life Specialists
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
GNWGenworth Financial, Inc.3.31B8.3012.21-3.09%3.1%2.24%2.65%0.16
MHNCMaiden Holdings North America, Ltd.1.58B15.87-7.90-2.92%-247.48%-405.36%

Profit & Loss

Dec 2008Dec 2009Dec 2010Dec 2011Dec 2020Dec 2021Dec 2022Dec 2024
Revenue+419.77B983.15B1.25T1.64T098.72M58.13M56.44M
Revenue Growth %-1.34%0.27%0.31%-1%--0.41%-0.03%
Medical Costs & Claims+1.25B38.73B5.81B5.03B0000
Medical Cost Ratio %--------
Gross Profit+418.51B944.42B1.24T1.64T098.72M58.13M56.44M
Gross Margin %--------
Gross Profit Growth %-1.26%0.32%0.32%-1%--0.41%-0.03%
Operating Expenses+14.97B042.18B53.89B8.48M36.02M118.53M35.35M
OpEx / Revenue %--------
Depreciation & Amortization00008.69M19.33M228.49K0
Combined Ratio %--------
Operating Income+403.54B62.4B1.2T1.58T8.48M26.66M75.32M21.09M
Operating Margin %--------
Operating Income Growth %--0.85%18.23%0.32%-1%2.14%1.83%-0.72%
EBITDA+403.54B62.4B1.2T1.58T17.17M45.99M75.55M21.09M
EBITDA Margin %--------
Interest Expense034.43B36.47B34.16B019.33M19.33M19.27M
Non-Operating Income001.09T1.52T000201.74M
Pretax Income+18.79B62.4B71.19B30.45B026.66M55.99M-199.91M
Pretax Margin %--------
Income Tax+01.34B1.33B1.93B015K557K1.05M
Effective Tax Rate %--------
Net Income+18.79B61.06B69.87B28.52B026.64M55.43M-200.97M
Net Margin %--------
Net Income Growth %-2.25%0.14%-0.59%-1%-1.08%-4.63%
EPS (Diluted)+0.000.000.000.000.000.310.64-2.01
EPS Growth %------1.06%-4.14%
EPS (Basic)0.000.000.000.000.000.310.64-2.01
Diluted Shares Outstanding59.34T70.06T71.37T72.9T84.94M86.55M87.16M99.9M

Balance Sheet

Dec 2008Dec 2009Dec 2010Dec 2011Dec 2020Dec 2021Dec 2022Dec 2024
Total Assets+2.13B2.64B2.98B3.35T2.95M2.32M1.85M1.32B
Asset Growth %-0.24%0.13%1123.55%-1%-0.21%-0.2%711.56%
Total Investment Assets+0002.02T0822.61K160.32K0
Long-Term Investments00000-66.09K80.16K0
Short-Term Investments00000888.7K80.16K0
Total Current Assets+131.9M107.4M96.2M570.75B1.46M908.21K1.09M55.54M
Cash & Equivalents131.9M107.4M96.2M188.08B1.46M888.7K633.68K34.73M
Receivables0001000K5.78K19.51K452.12K1000K
Other Current Assets00000-888.7K-80.16K0
Goodwill & Intangibles+00098.75B0000
Goodwill00000000
Intangible Assets000382.67B0000
PP&E (Net)00000000
Other Assets0000066.09K00
Total Liabilities00002.42M1.94M1.56M1.27B
Total Debt+00000000
Net Debt-131.9M-107.4M-96.2M-188.08B-1.46M-888.66K-633.68K-34.73M
Long-Term Debt00000000
Short-Term Debt00000000
Total Current Liabilities+00000000
Accounts Payable00000000
Deferred Revenue00000000
Other Current Liabilities00000000
Deferred Taxes00000000
Other Liabilities000001.94M00
Total Equity+509.8M676.5M750.2M768.98B527.82K384.26K284.58K45.19M
Equity Growth %-0.33%0.11%1024.03%-1%-0.27%-0.26%157.81%
Shareholders Equity509.8M676.5M750.2M768.64B527.82K384.26K284.58K45.19M
Minority Interest000338M0000
Retained Earnings000128.65B-615.84M-498.3K-442.86K-687.91M
Common Stock000732M898K923K1.49K1.5M
Accumulated OCI00064.06B23.86K-12.21K-41.23K-32.73M
Return on Equity (ROE)36.87%102.94%97.94%0.07%-58.43%165.76%-8.84%
Return on Assets (ROA)8.83%25.63%24.87%0.02%-10.11%26.59%-0.3%
Equity / Assets--------
Debt / Equity--------
Book Value per Share0.000.000.000.010.010.000.000.45
Tangible BV per Share--------

Cash Flow

Dec 2008Dec 2009Dec 2010Dec 2011Dec 2020Dec 2021Dec 2022Dec 2024
Cash from Operations+589.39B41.98B151.58B181.35B-541.77M0-195.93M-67.45M
Operating CF Growth %--0.93%2.61%0.2%-1%1%-0.66%
Operating CF / Revenue %--------
Net Income18.79B61.06B69.86B28.53B026.64M-60.04M-200.97M
Depreciation & Amortization1.31B7.36B7.21B8.6B8.69M000
Stock-Based Compensation-1.7B-5.47B-3.59B22.24B000-5.26M
Deferred Taxes00000000
Other Non-Cash Items570.98B-20.96B78.1B121.99B-584.02M-26.09M-112K138.78M
Working Capital Changes000024.87M-553.68K-135.78M0
Cash from Investing+-716.93B-173.43B-125.19B13.25B596.04M0188.79M77.74M
Capital Expenditures00000000
Acquisitions-108.64B-13.61B-4.89B635M0000
Purchase of Investments-479.24B-891.47B-1.03T-637.31B-36.82M0-95.56M-37.77M
Sale/Maturity of Investments1000K1000K1000K1000K1000K01000K1000K
Other Investing-458.19B531.44B-710.61B-374.67B127.47M0218.74M14.57M
Cash from Financing+223.71B105.89B-37.24B-20.92B-30.13M0-10.98M-3.73M
Dividends Paid-8.93B-12.65B-18.39B-20.92B0000
Share Repurchases0000-1K0-1.01M-3.73M
Stock Issued00000000
Debt Issuance (Net)00000000
Other Financing232.65B118.54B-18.84B0-30.13M0-10.98M-3.73M
Net Change in Cash+96.17B-24.5B-11.24B-25.14B28.55M0-19.46M5.41M
Exchange Rate Effect01000K-1000K-1000K1000K0-1000K-1000K
Cash at Beginning35.73B131.9B107.4B0107.28M135.83M66.09M42.68M
Cash at End131.9B107.4B96.15B-25.14B135.83M135.83M46.62M48.08M
Free Cash Flow+589.39B41.98B151.58B181.35B-541.77M0-195.93M-67.45M
FCF Growth %--0.93%2.61%0.2%-1%1%-0.66%
FCF Margin %--------
FCF per Share0.01000-6.38--2.25-0.68

Key Ratios

Metric20082009201020112020202120222024
Combined Ratio3.87%3.94%3.85%3.59%-36.49%203.89%62.63%
Medical Cost Ratio0.3%3.94%0.47%0.31%-0%0%0%
Return on Equity (ROE)3686.54%10293.85%9794.07%7.41%-5842.73%16575.66%-883.82%
Return on Assets (ROA)882.93%2562.5%2486.56%1.7%-1010.99%2658.94%-30.5%
Equity / Assets23.95%25.66%25.15%22.93%17.9%16.54%15.41%3.43%
Book Value / Share0000.010.01000.45
Revenue Growth-134.21%26.94%31.44%-100%--41.11%-2.92%

Revenue by Segment

2012201320142015201620172018
Diversified Reinsurance795.34M762.06M854.03M744.88M724.12M823.37M112.49M
Diversified Reinsurance Growth--4.18%12.07%-12.78%-2.79%13.70%-86.34%
AmTrust Reinsurance--1.38B1.68B1.84B1.91B-
AmTrust Reinsurance Growth---22.19%9.47%3.58%-
AmTrust Quota Share Reinsurance727.78M988.9M-----
AmTrust Quota Share Reinsurance Growth-35.88%-----
NGHC Quota Share-249.92M-----
NGHC Quota Share Growth-------
ACAC Quota Share280.66M------
ACAC Quota Share Growth-------

Frequently Asked Questions

Growth & Financials

Maiden Holdings North America, Ltd. (MHNC) saw revenue decline by 2.9% over the past year.

Maiden Holdings North America, Ltd. (MHNC) reported a net loss of $152.3M for fiscal year 2024.

Dividend & Returns

Maiden Holdings North America, Ltd. (MHNC) has a return on equity (ROE) of -883.8%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Maiden Holdings North America, Ltd. (MHNC) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.